Bell Investment Advisors, Inc Ironwood Pharmaceuticals Inc Transaction History
Bell Investment Advisors, Inc
- $533 Million
- Q4 2024
A detailed history of Bell Investment Advisors, Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 48 shares of IRWD stock, worth $74. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48
Previous 216
77.78%
Holding current value
$74
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IRWD
# of Institutions
244Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$35.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$30.3 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$25.4 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$18.2 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$14.7 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $238M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...